AVBP Smart Money
ArriVent BioPharma, Inc.
1W: -18.3%
1M: -47.4%
3M: -48.7%
YTD: -26.0%
1Y: -17.2%
$15.40
+0.04 (+0.26%)
Pre-Market: $15.20 (-0.20, -1.30%)
Weekly Expected Move ±26.1%
$10
$16
$21
$26
$32
Credit Risk of going bust: lower than 76% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), ArriVent BioPharma, Inc. would be worth roughly what it owes.
Total debt $351K against a stock market value of $759.3M.
Distance to default 8.74 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $176K (short-term plus half of long-term), stock volatility 91.5%; Altman Z'' 13.01. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), ArriVent BioPharma, Inc. would be worth roughly what it owes.
Total debt $351K against a stock market value of $759.3M.
Distance to default 8.74 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $176K (short-term plus half of long-term), stock volatility 91.5%; Altman Z'' 13.01. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026176
Institutions Holding
+22 vs prior
212.1%
Ownership
+84.61%
39
New
71
Increased
45
Reduced
15
Closed
👔 Insider Trades
2 records🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 4,515,531 | $157M | +114,448 | 2026-06-30 | Filing |
| INFINITUM ASSET MANAGEMENT, LLC | 4,438,384 | $154M | +289,461 | 2026-06-30 | Filing |
| HHLR ADVISORS, LTD. | 3,929,117 | $136M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,250,396 | $113M | +720,095 | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 3,027,328 | $105M | — | 2026-06-30 | Filing |
| FMR LLC | 2,778,959 | $97M | -237,173 | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 1,971,054 | $68M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,774,873 | $62M | +245,980 | 2026-06-30 | Filing |
| Sofinnova Investments, Inc. | 1,696,752 | $59M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 1,692,986 | $59M | +271,571 | 2026-06-30 | Filing |
| Vivo Capital, LLC | 1,682,097 | $58M | +796,181 | 2026-06-30 | Filing |
| NOVO HOLDINGS A/S | 1,500,000 | $52M | -442,142 | 2026-06-30 | Filing |
| General Catalyst Group Management, LLC | 1,494,786 | $52M | — | 2026-06-30 | Filing |
| Logos Global Management LP | 1,000,000 | $35M | +650,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 972,626 | $34M | +168,974 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 872,011 | $30M | +503,216 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 853,723 | $30M | +296 | 2026-06-30 | Filing |
| HSG Holding Ltd | 663,308 | $23M | — | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 566,796 | $20M | -181,399 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 438,664 | $15M | +12,741 | 2026-06-30 | Filing |